Compare ImmunityBio Inc. Common Stock (IBRX) vs Cloudflare Inc (NET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Cloudflare Inc — how do they compare? ImmunityBio Inc. Common Stock trades at $10.02 (market cap $10.33B), while Cloudflare Inc trades at $344 (market cap $122.12B). The key difference: Cloudflare Inc is far larger — about 11.8× ImmunityBio Inc. Common Stock's market cap, and ImmunityBio Inc. Common Stock is more actively traded (11,745,198 versus 2,321,930). Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Cloudflare Inc for 61 Days on average.
| IBRX | NET | |
|---|---|---|
Market Cap | $10.33B | $122.12B |
Volume | 11,745,198 | 2,321,930 |
Sector | Health | Technology |
52-Week High | $11.55 | $359.60 |
52-Week Low | $1.98 | $160.16 |
Typical Hold Time | 0 Days | 61 Days |
Enterprise Value | $10.79B | $121.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Cloudflare (NET) trades at $341.70, down 3.75% on the day, with a bullish technical signal from moving averages and neutral oscillators. Revenue growth is strong, reaching $2.17 billion in 2025, but the company remains unprofitable with a net income margin of -8.21%. Recent news highlights product launches like Cloudflare Basin and partnerships, such as with Deutsche Telekom, driving positive sentiment. The stock is near its 52-week high, reflecting investor optimism around its AI and security offerings.
Outlook is mixed: robust revenue growth and analyst bullishness (70.7% buy ratings) support upside, but high valuations (P/S of 48.03) and persistent losses pose risks. Investors should weigh growth potential against profitability challenges and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Cloudflare Inc
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Read more on NET →
